Correction to: “Bateman BG, Nunley WC Jr, Kitchin JD III: Surgical management of distal tube obstruction—are we making progress? Fertil Steril 48:523, 1987”

1988 ◽  
Vol 49 (2) ◽  
pp. 382
Author(s):  
Bruce G. Bateman
1995 ◽  
Vol 109 (2) ◽  
pp. 159-160 ◽  
Author(s):  
Yaron Bar-Lavie ◽  
Albert Gatot ◽  
Ferit Tovi

AbstractA case of intraoperative tracheostomy tube obstruction is reported. The clinical features and the chain of events leading to the diagnosis of cuff herniation are presented. The different mechanisms of herniation are discussed. In the present case we speculate that a manufacturing defect together with nitrous oxide diffusion into the cuff caused dilatation and herniation of the latter which led to obstruction of the distal tube lumen. We draw attention to this rare but life-threatening complication.


Author(s):  
Philip P. Chen

Tube shunt obstruction is a relatively common complication, with reported rates up to 15%. Tube obstructions can be divided into 2 basic types: 1) distal tube obstruction in the anterior chamber, ciliary sulcus, or pars plana; and 2) proximal tube obstruction at the tubeplate junction. Occasionally tube obstruction may lead the surgeon and patient to believe that the tube shunt was never successful at controlling intraocular pressure (IOP) postoperatively. This complication generally has a high impact on the patient’s postoperative course. Preoperative planning and careful surgical technique can avoid many cases of obstruction. Distal tube obstruction is typically a serious postoperative complication, with a sudden elevation in IOP resulting in pain, inflammation, and worsened vision. The distal end of the tube may be obstructed by blood, fibrin, iris, vitreous, lens material, silicone oil, and/ or viscoelastic. Treatment is tailored to the immediate cause. No matter what the cause of obstruction, if tube repositioning becomes necessary, the use of tube extenders, available either commercially or created with readily available 22-gauge angiocatheter sleeves and silicone tubing (used for nasolacrimal duct intubation), facilitate this procedure if the tube is too short to reposition (see Chapter 30). If a blood clot or fibrin is present, observation with use of ocular hypotensive agents and frequent (every 1–2 hours) application of topical prednisolone acetate, 1% may be sufficient. Tissue plasminogen activator (tPA) also may be injected into the anterior chamber to rapidly resolve the clot. The usual dose of tPA is 12.5 μg in 0.1 cc (0.1 mL) and is readily available from most hospital pharmacies. Multiple injections may be required, but concerns about cost have lessened with the advent of a recombinant form of tPA. In one series of 36 patients treated with tPA after tube shunt surgery, severe hyphema, flat anterior chamber, and profound hypotony were seen after 11% (6 of 55) tPA injections. Blood in the tube may be flushed out with balanced saline solution, using a 27-gauge cannula inserted into the eye through a paracentesis wound. If the tube is buried in the iris, pilocarpine may pull the iris out of the tube.


2019 ◽  
Vol 4 (5) ◽  
pp. 857-869
Author(s):  
Oksana A. Jackson ◽  
Alison E. Kaye

Purpose The purpose of this tutorial was to describe the surgical management of palate-related abnormalities associated with 22q11.2 deletion syndrome. Craniofacial differences in 22q11.2 deletion syndrome may include overt or occult clefting of the palate and/or lip along with oropharyngeal variances that may lead to velopharyngeal dysfunction. This chapter will describe these circumstances, including incidence, diagnosis, and indications for surgical intervention. Speech assessment and imaging of the velopharyngeal system will be discussed as it relates to preoperative evaluation and surgical decision making. Important for patients with 22q11.2 deletion syndrome is appropriate preoperative screening to assess for internal carotid artery positioning, cervical spine abnormalities, and obstructive sleep apnea. Timing of surgery as well as different techniques, common complications, and outcomes will also be discussed. Conclusion Management of velopharyngeal dysfunction in patients with 22q11.2 deletion syndrome is challenging and requires thoughtful preoperative assessment and planning as well as a careful surgical technique.


2001 ◽  
Vol 120 (5) ◽  
pp. A401-A401 ◽  
Author(s):  
D EFRON ◽  
K LILLEMOE ◽  
J CAMERON ◽  
S TIERNEY ◽  
S ABRAHAM ◽  
...  

2006 ◽  
Vol 175 (4S) ◽  
pp. 112-112
Author(s):  
Jennifer T. Anger ◽  
Mark S. Litwin ◽  
Qin Wang ◽  
Er Chen ◽  
Chris L. Pashos ◽  
...  

2006 ◽  
Vol 175 (4S) ◽  
pp. 549-549 ◽  
Author(s):  
Charles D. Scales ◽  
David Kang ◽  
Ravi Munver ◽  
Brian K. Auge ◽  
Wesley Ekeruo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document